- Aurora Spine (OTCQB:ASAPF) has received U.S. FDA 510k clearance for its proprietary APOLLO Anterior Cervical Plate (ACP) system.
- This new product will also support sales of the company's TiNANO cervical cages and enable us to develop additional products around its DEXA patent, which matches implants to a patient’s bone density.
- "This approval is a great step for Aurora in fiscal 2021 and we are hopeful to deliver several new key products throughout the year," CEO Trent Northcutt said.